Skip to main content
. 2008 Mar 28;14(12):1885–1890. doi: 10.3748/wjg.14.1885

Figure 2.

Figure 2

A: Before infliximab therapy: A stenotic lesion of the terminal ileum, with narrow lumen (white arrows) and increased thickness of the intestinal wall. The markers assess the length. The iliac vessel is indicated (circle); B: After infliximab therapy (22 cycles): The same ileal segment with an increased lumen diameter (12 mm) and reduced thickness of the intestinal wall. The iliac vessel is indicated (circle).